JENNIFER WHITSELL: Open Payments
NPI 1457809279 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,750 in 251 payments from 23 companies in 2025. Trend: 2023 $2,111 · 2024 $3,394 · 2025 $3,750
Food & beverage: $3,730Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $986 |
| Janssen Biotech, Inc. | 33 | $425 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $307 |
| Madrigal Pharmaceuticals | 15 | $264 |
| GENZYME CORPORATION | 11 | $254 |
| Ardelyx, Inc. | 17 | $230 |
| Lilly USA, LLC | 15 | $228 |
| Gilead Sciences, Inc. | 17 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $161 |
| Ipsen Biopharmaceuticals, Inc | 11 | $153 |
Products named: RINVOQ, TREMFYA, DUPIXENT, REZDIFFRA, ENTYVIO, IBSRELA, OMVOH, CREON.
Industry payments across KY — which companies pay providers there.
